Keeping the Wolves at Bay: Antitoxins of Prokaryotic Type II Toxin-Antitoxin Systems by Wai Ting Chan et al.
REVIEW
published: 22 March 2016
doi: 10.3389/fmolb.2016.00009
Frontiers in Molecular Biosciences | www.frontiersin.org 1 March 2016 | Volume 3 | Article 9
Edited by:
Brian M. Baker,
University of Notre Dame, USA
Reviewed by:
Kurt Henry Piepenbrink,
The University of Maryland, USA
Andrew Benjamin Herr,
Cincinnati Children’s Hospital Medical
Center, USA
*Correspondence:
Manuel Espinosa
mespinosa@cib.csic.es;
Chew Chieng Yeo
chewchieng@gmail.com
Specialty section:
This article was submitted to
Molecular Recognition,
a section of the journal
Frontiers in Molecular Biosciences
Received: 21 December 2015
Accepted: 04 March 2016
Published: 22 March 2016
Citation:
Chan WT, Espinosa M and Yeo CC
(2016) Keeping the Wolves at Bay:
Antitoxins of Prokaryotic Type II
Toxin-Antitoxin Systems.
Front. Mol. Biosci. 3:9.
doi: 10.3389/fmolb.2016.00009
Keeping the Wolves at Bay:
Antitoxins of Prokaryotic Type II
Toxin-Antitoxin Systems
Wai Ting Chan 1, Manuel Espinosa 1* and Chew Chieng Yeo 2*
1Molecular Microbiology and Infection Biology, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones
Científicas, Madrid, Spain, 2 Faculty of Medicine, Biomedical Research Centre, Universiti Sultan Zainal Abidin, Kuala
Terengganu, Malaysia
In their initial stages of discovery, prokaryotic toxin-antitoxin (TA) systems were confined
to bacterial plasmids where they function to mediate the maintenance and stability
of usually low- to medium-copy number plasmids through the post-segregational
killing of any plasmid-free daughter cells that developed. Their eventual discovery as
nearly ubiquitous and repetitive elements in bacterial chromosomes led to a wealth of
knowledge and scientific debate as to their diversity and functionality in the prokaryotic
lifestyle. Currently categorized into six different types designated types I–VI, type II TA
systems are the best characterized. These generally comprised of two genes encoding
a proteic toxin and its corresponding proteic antitoxin, respectively. Under normal growth
conditions, the stable toxin is prevented from exerting its lethal effect through tight
binding with the less stable antitoxin partner, forming a non-lethal TA protein complex.
Besides binding with its cognate toxin, the antitoxin also plays a role in regulating the
expression of the type II TA operon by binding to the operator site, thereby repressing
transcription from the TA promoter. In most cases, full repression is observed in the
presence of the TA complex as binding of the toxin enhances the DNA binding capability
of the antitoxin. TA systems have been implicated in a gamut of prokaryotic cellular
functions such as being mediators of programmed cell death as well as persistence
or dormancy, biofilm formation, as defensive weapons against bacteriophage infections
and as virulence factors in pathogenic bacteria. It is thus apparent that these antitoxins,
as DNA-binding proteins, play an essential role in modulating the prokaryotic lifestyle
whilst at the same time preventing the lethal action of the toxins under normal growth
conditions, i.e., keeping the proverbial wolves at bay. In this review, we will cover the
diversity and characteristics of various type II TA antitoxins. We shall also look into some
interesting deviations from the canonical type II TA systems such as tripartite TA systems
where the regulatory role is played by a third party protein and not the antitoxin, and a
unique TA system encoding a single protein with both toxin as well as antitoxin domains.
Keywords: toxin-antitoxin, DNA-binding motifs, transcriptional repressor proteins, autoregulation, conditional
cooperativity
Abbreviations: TA, toxin-antitoxin; HTH, helix-turn-helix; RHH, ribbon-helix-helix; FIS, factor for inversion stimulation.
Chan et al. Prokaryotic Type II Antitoxins
INTRODUCTION
The profusion of toxin-antitoxin (TA) genes among the realm
of prokaryotes has sparked the interest of researchers to reveal
the rationale of TA existence. One could hardly imagine the
reason behind the finding that TA, which is mainly found in
the genomes of bacteria and archaea, can be present up to 88
copies in Mycobacterium tuberculosis, although only 30 of them
are functional (Ramage et al., 2009). In general (but not in all
cases), a TA system is comprised of two genes, the antitoxin gene
and its cognate toxin gene, which are located adjacent to each
other. There are various modes of action by the toxin protein to
exert its toxicity, but the most common ones involve inhibition
of translation or replication, or targeting the cell wall synthesis
of the host cells. TA systems, which have not been found in
eukaryotes are, however, also able to poison eukaryotic cells
because eukaryotes share common transcription and translation
machineries with prokaryotes (Christensen et al., 2001; Pimentel
et al., 2005; Nariya and Inouye, 2008; Amitai et al., 2009; Hurley
and Woychik, 2009; Yamaguchi and Inouye, 2009; Agarwal et al.,
2010; Dienemann et al., 2011; Castro-Roa et al., 2013; Germain
et al., 2013). The product of the antitoxin gene, which can
be either RNA or protein, is usually less stable compared to
the toxin protein. Depending on the mechanism by which the
antitoxin neutralizes the toxin, TAs have been categorized into
six different types: (i) Type I, in which the antitoxin mRNA
binds to its complementary toxin mRNA to prevent translation
of the toxin gene; (ii) Type II, the antitoxin is a protein that
forms a stable complex with the toxin protein and blocking the
active site of the toxin under normal growth conditions; (iii) Type
III, the antitoxin is an RNA with multiple tandem repeats that
binds directly to the toxin protein rendering the toxin inactive;
(iv) Type IV, the antitoxin protein does not bind to the toxin,
but antagonize the toxin effect by competing for binding to
the cellular target; and (v) Type V, the antitoxin protein is an
RNase that cleaves directly its cognate toxin mRNA (Alonso
et al., 2007; Hayes and Van Melderen, 2011; Masuda et al., 2012;
Cataudella et al., 2013; Unterholzner et al., 2013; Barbosa et al.,
2015). A likely new type of TA system (a possible type VI) was
recently discovered in Caulobater crescentuswhere both the SocA
antitoxin and SocB toxin are proteins, as in types II and IV
TA systems. However, in this case, the SocA antitoxin functions
as a ClpXP protease adaptor for the SocB toxin, promoting
degradation of the toxin and thereby abolishing its lethality
(Aakre et al., 2013; Markovski and Wickner, 2013). Thus, in a
type VI TA system, the toxin is the unstable partner whereas in
type II TA systems, the antitoxins are the labile partners due to
their susceptibility to protease degradation. To date, TA systems
belonging to types I and II are the most abundant in prokaryotes
with type II TAs being the best characterized (Hayes and Van
Melderen, 2011; Unterholzner et al., 2013; Bertram and Schuster,
2014; Hayes and Kêdzierska, 2014).
TA genes, which do not seem to be essential to the host cells
(VanMelderen and Saavedra De Bast, 2009; VanMelderen, 2010),
have been linked in countless ways to the lifestyle of the bacteria.
The function of plasmid-encoded TAs has been commonly
recognized as to stabilize the plasmid by a phenomenon denoted
as post-segregational killing of the daughter cells that do not
inherit its parental plasmid (Jaffe et al., 1985; Gerdes et al.,
1986) or “addiction,” as once the cells acquire the TA-encoded
plasmid horizontally, the cells are no longer able to survive if they
lost that plasmid (Lehnherr and Yarmolinsky, 1995; Hernández-
Arriaga et al., 2014). Nevertheless, the chromosomally-encoded
TA genes are known to have broader impact to the host cells.
Since the consequences of toxin effect can be bactericidal or
bacteriostatic, chromosomally-encoded TAs have been related to
altruistic cell death or stress response when the cells are under
unfavorable circumstances. Altruistic cell death adopted the idea
of bacterial cells living as a community, and when under stressful
states like scarcity in nutrition, some of the cells will “sacrifice”
themselves via triggering of their TA systems, subsequently lysing
and releasing nutrients for the rest of their populations’ need
(Aizenman et al., 1996; Engelberg-Kulka and Glaser, 1999). Of
course one could argue that instead of altruism, cannibalism
(e.g., in Bacillus subtilis; González-Pastor, 2011) or fratricide (e.g.,
in Streptococcus pneumoniae; Eldholm et al., 2009) would more
likely had happened for bacteria, which are the more primitive
life forms. As activation of most of the toxins leads to cell stasis,
the postulation of TAs involving in stress response is more widely
accepted (Gerdes et al., 2005). The stress response mediated
by TAs was well-demonstrated by the persistence phenomenon
observed in Escherichia coli and other bacteria. Persister cells
refer to a small portion of cells among isogenic antibiotic-
sensitive bacterial population that stochastically switch to slow
growth (or a quasi-dormant state) leading to multidrug tolerance
when exposed to antibiotics (Lewis, 2010). In the persister
cells, the increased levels of the signaling nucleotide (p)ppGpp
(guanosine pentaphosphate/tetraphosphate) trigger slow growth
by activating certain TAs through a regulatory cascade, which
is dependent on Lon protease and inorganic polyphosphate
(Maisonneuve et al., 2013). There are also other studies that
demonstrated the involvement of chromosomally-encoded TAs
in biofilm formation, increased survival rate, colonization of
new niches, phage abortive infection, maintenance of bacterial
mobilomes, virulence of pathogenic bacteria, and as anti-
addiction modules (Christensen et al., 2001; Rowe-Magnus et al.,
2003; Szekeres et al., 2007; Saavedra De Bast et al., 2008; Harrison
et al., 2009; Mine et al., 2009; Hallez et al., 2010; Makarova et al.,
2011; Armalyte et al., 2012; Norton and Mulvey, 2012; Cheng
et al., 2014). Thus, the diversity of TA systems in prokaryotes is
reflected in their diversity of cellular function.
ANTITOXINS NEUTRALIZE THE
LETHALITY OF THEIR COGNATE TOXINS
AND ALSO FUNCTION AS DNA-BINDING
PROTEINS THAT MODULATE THE
PROKARYOTIC LIFESTYLE
Type II TA systems are so far, the best studied of the TA
families. Like other systems, Type II TAs are usually comprised
of two genes with the antitoxin gene preceding the toxin gene,
and with both genes co-transcribed from a single promoter
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located upstream of the antitoxin gene (Leplae et al., 2011).
In general, the two TA genes overlap by a few nucleotides,
indicating coupled translation of the two genes. Under normal
conditions, the antitoxin protein binds avidly to the toxin protein
to safeguard its harmfulness to the cells, as it has also been
shown by determination of the three dimensional structures of
TA complexes. However, because the antitoxin protein seems
to be structurally partially folded (Cherny et al., 2005), it is
thus more fragile and susceptible to the degradation by the host
proteases (e.g., Lon or Clp); antitoxin cleavage would release the
more stable toxin protein to act on its cellular target. Hence, the
antitoxin protein needs to be constantly replenished in order to
avoid a surfeit of toxin proteins. This explains the organization of
the majority of type II TA operons: the antitoxin gene preceding
the toxin gene would enable the antitoxin to be transcribed and
translated before synthesis of the toxin starts.
Toxins target various cellular structures and essential
molecular processes and thus, hinder cellular activities (Hayes
and Van Melderen, 2011; Hayes and Kêdzierska, 2014). Majority
of class II toxins that have been examined to date act as
endoribonucleases and thus, inhibit the translation machinery
(Yamaguchi and Inouye, 2009; Yamaguchi et al., 2011). Some
of these endoribonucleases, such as the MazF toxin, cleave free
mRNA in a sequence-dependent manner (Zhang et al., 2003),
whereas other endoribonuclease toxins, such as RelE, target
mRNA associated with ribosomes (Pedersen et al., 2003). Some
type II toxins interfere with the translation process by other
means such as the cleavage of initiator tRNA by the VapC toxins
of Shigella flexneri and Salmonella enterica serovar Typhimurium
(Winther and Gerdes, 2011), or phosphorylation of elongation
factor EF-Tu by the E. coli-encoded HipA toxin and the
bacteriophage P1-encoded Doc toxin (Schumacher et al., 2009;
Cruz et al., 2014). On the other hand, certain type II toxins (such
as CcdB and ParE) affect DNA replication by direct inhibition
of gyrase activity, which is required to relieve supercoiling that
occurs ahead of the replication fork (Bernard and Couturier,
1992; Yuan et al., 2010). The ζ and PezT toxins blocks cell wall
synthesis by phosphorylating peptidoglycan precursors, thereby
inhibiting the first step in peptidoglycan synthesis (Mutschler
et al., 2011).
Type II antitoxins abrogate the lethality of their cognate
toxins through a toxin-binding domain, which is usually natively
unstructured until formation of the toxin-antitoxin complex.
One of the hallmarks of toxin inactivation is a direct interaction
whereby the antitoxin wraps around the toxin and inhibits toxin
activity by blocking or masking the toxin active site (Blower et al.,
2011; Bøggild et al., 2012; Schureck et al., 2014). For example, the
E. coli-encoded MazE antitoxin wraps across the surface of the
MazF toxin, blocking the active site as well as forcing out the S1-
S2 loop that stabilizes the catalytic triad of the toxin (Kamada
et al., 2003). In the case of the ζ and PezT toxins, inactivation
is due to the respective cognate ε or PezA antitoxin sterically
hindering ATP/GTP binding within the toxin (Meinhart et al.,
2003; Khoo et al., 2007). The Caulobacter crescentus-encoded
ParD antitoxin inhibits its cognate ParE toxin by binding as a
dimer to a conserved complementary patch at the C-terminus
of ParE without inducing conformational changes (Dalton and
Crosson, 2010). In contrast, binding of the E. coli-encoded
RelB antitoxin inhibits the RelE toxin by perturbing the toxin
structure, specifically through displacement of a flexible α-helix
at the C-terminal that contains the Tyr-87 residue essential for
RelE activity (Li et al., 2009). Similarly, the VapB5 antitoxin ofM.
tuberculosis act to prevent its cognate VapC5 toxin from binding
Mg2+ as a co-factor by reorienting the side-chain of VapC5
Arg-112, locking the VapC5 Glu-57 residue in an unfavorable
conformation to bind Mg2+ (Miallau et al., 2009). In some TA
complexes, the antitoxin binds to the toxin but does not occlude
the active site of the toxin. The E. coli-encoded HipB antitoxin
binds far from the active site of its cognate HipA toxin and
functions to inhibit the toxin activity by locking the toxin in an
inactive open conformation (Schumacher et al., 2009). Similarly,
the HigA antitoxin of Proteus vulgaris only makes two regions
of contact with the HigB toxin, both of which are distant from
the HigB active site. The HigB toxin functions as a ribosome-
dependent endoribonuclease and it was proposed that binding of
HigA sterically inhibits HigB from interacting with mRNA in the
A site of the ribosome (Schureck et al., 2014).
The antitoxin protein is not only the nemesis of its cognate
toxin, but also the key factor that regulates transcription of the
TA operon. The antitoxin is generally a DNA-binding protein
that binds, albeit usually weakly, to the operator of the operon
to repress its own transcription; whereas the toxin protein,
which does not bind to the DNA upstream of the operon,
usually serves as a co-repressor, by binding to the antitoxin
protein and changing the conformation of the antitoxin-DNA
complex, which lead to further repression (Bertram and Schuster,
2014; Hayes and Kêdzierska, 2014; Ke˛dzierska and Hayes, 2016).
In some cases, the molar ratio of antitoxin and toxin has
great impact on the formation of the TA complex in terms
of stoichiometries (Gelens et al., 2013). More importantly, TA
complexes with different stoichiometries have different affinity to
the binding of the operator (Overgaard et al., 2008; Garcia-Pino
et al., 2010; see below). Therefore, the ratio of the antitoxin and
toxin is very crucial to the regulation of the transcription of the
TA operon and to determine the lifestyle and fate of the bacterial
host.
DNA-BINDING DOMAINS FOUND IN
ANTITOXINS: HELIX-TURN-HELIX (HTH),
RIBBON-HELIX-HELIX (RHH) FOLD, AND
SpoVT/AbrB-TYPE
Concerning the three-dimensional structure of the TAs, several
of them have been determined, either the antitoxin alone or in
complex with the cognate toxin. In most cases, the antitoxin
protein appears to be divided into two domains: the N-terminal
domain usually comprises the DNA binding region, whereas
the C-terminal domain is generally involved in the interaction
with the cognate toxin to offset its toxicity. These two domains
may be interconnected by a flexible small loop or hinge-
like region. Determination of the crystal structure of the TA
complexes (mostly without DNA) has been achieved for an
increasing number of them. In general, the structure of the DNA-
binding domains of the antitoxins can be grouped into three
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different types, namely helix-turn-helix (HTH), ribbon-helix-
helix (RHH), and SpoVT/AbrB-type (Table 1; Figure 1). The
HTHmotif consists of around 20 amino acid residues distributed
into two α-helices separated by a short turn, generally mediated
by a Gly residue (Figure 1A). The second helix of the HTHmotif
(also termed “the reading head”) recognizes and binds to the
target DNA via a number of hydrogen bonds and hydrophobic
interactions, which occur between specific side chains of the
protein and the exposed bases and thymine methyl groups within
the major groove of the DNA, whereas the first helix, and
sometimes a third one, helps to stabilize the structure of the
motif (Brennan and Matthews, 1989). The HTH motif has been
reported in a number of prokaryotic DNA repressor proteins as
well as in eukaryotes (Brennan andMatthews, 1989). Examples of
the existence of the HTH motif in solved structures of antitoxins
include PezA (Khoo et al., 2007) as well as HigA (Schureck et al.,
2014). Another example of antitoxin harboring the HTHmotif is
MsqA, although in this case the motif is present at the C-terminal
region of the protein; the N-terminal region having a Zn-binding
domain involved in the interaction with its cognate toxin MsqR
(Brown et al., 2009).
The RHH proteins have been found mostly in prokaryotes.
These structures are arranged as two antiparallel β-strands
that generate a ribbon (Figure 1B); each strand comes from
one of two protein monomers and they are involved both in
dimer formation and in specific interactions with the DNA
bases in the antitoxin DNA target. In the simplest form,
like the transcriptional repressor protein CopG (45 residues
per protomer), or the Salmonella phage P22 Arc repressor
(53 residues per protomer) the ribbon participates in DNA
recognition and in the dimerization process, so that the proteins
would be mostly in a disordered state if it were a monomer.
However, no monomers of the protein seem to exist, and
mutational analyses indicated that dimerization and folding
could be considered as part of the same process, and the proteins
would only exist as dimers (Milla et al., 1995; Gomis-Rüth
et al., 1998). Perhaps, and lacking further information on the
structure of other antitoxins, the RHH motif seems to be the
most common structural motif in antitoxins, as it is present
in CcdA (Madl et al., 2006), ParD (Oberer et al., 2007), RelB
(Bøggild et al., 2012), DinJ (Liang et al., 2014), FitA (Mattison
et al., 2006), and VapB (Min et al., 2012).
The number of antitoxins with a SpoVT/AbrB-type domain
is also steadily increasing. They all share similarities to the
transcriptional regulator AbrB, found in the Gram-positive
bacterium B. subtilis and that is involved in the regulation of
many genes. The structure of the DNA-binding domain of AbrB
(Figure 1C) revealed the presence of a specific domain, in which
twomolecules (each having two β-hairpins) dimerizes to generate
a so-called layered “β-sandwich.” A similar structure has been
reported for the S. flexneri VapBC TA pair, in which four N-
terminal antitoxin VapB domains generate two DNA-binding
domains; each of these domains is constructed by a three-
stranded antiparallel β-sheets, and a four-stranded antiparallel
β-sheet. These arrangements form a strand-switched dimer
interface in which the two β-sheets are tightly packed against each
other, thus generating the DNA-binding domain (Dienemann
et al., 2011). Similar to VapB, but exhibiting a simpler structure
is the MazE antitoxin (Kamada et al., 2003; Bobay et al., 2005),
which, in turn has structural homology to the well-characterized
Kis antitoxin (Kamphuis et al., 2007a,b).
The DNA binding targets of the antitoxin proteins are usually
perfect or imperfect palindromic sequences (Khoo et al., 2007;
Chan et al., 2011) that overlap with all or part of the promoter
region; thus, binding of the antitoxin to its target would thwart
the binding of the host RNA polymerase to the promoter
resulting in transcription inhibition (see below).
AUTOREGULATION AS A PARADIGM OF
TYPE II TA LOCI: STRUCTURE AND
FUNCTION OF THE MazE ANTITOXIN
MazEF is the first chromosomally-encoded TA discovered in E.
coli (Aizenman et al., 1996). The mazEF operon is located in
the E. coli rel locus, downstream of the relA gene. Expression
of mazEF was shown to be regulated by the cellular levels
of ppGpp, the product of the RelA protein. During amino
acid starvation, increased levels of the alarmone guanosine
tetraphosphate (ppGpp) lead to inhibition of transcription of
mazEF and triggers programmed cell death (Aizenman et al.,
1996). The MazF toxin is an endoribonuclease that cleaves
cellular mRNA at the specific sequence, 5′-ACA-3′ (Zhang et al.,
2003). Interestingly, MazF also cleaves ACA sites that are close
to the region upstream of the AUG start site of some specific
mRNAs, thus generating a pool of leaderless mRNAs. In addition,
MazF also targets 16S rRNA within 30S ribosomal subunits at
the decoding center, therefore removing 43 nucleotides from
the 3’ terminus that comprises the anti-Shine-Dalgarno. As a
result, a modified translation machinery is formed to selectively
translate the leaderless mRNAs to adapt to the stress condition
(Vesper et al., 2011). The antitoxin MazE harbors two domains:
(i) the N-terminus consists of a SpoVT/AbrB-type domain with
a swapped-hairpin β-strand motif that binds to the operator to
negatively autoregulate its transcription, and (ii) the C-terminal
domain is intrinsically disordered and upon binding to MazF
toxin will form an extended conformation that is more stable
and protected from the host protease degradation (Kamada et al.,
2003; Loris et al., 2003). The C-terminal tail of MazE is not
directly involved in DNA binding and remained disordered upon
interaction of the N-terminal domain with the DNA (Vesper
et al., 2011).
Along the same operon downstream ofmazEF is another open
reading frame calledmazG, which is co-transcribed withmazEF.
MazG is a pyrophosphohydrolase that hydrolyses dNTPs and
thus depletes ppGpp. However, MazG activity is also inhibited by
the MazEF complex (Gross et al., 2006). Therefore, during amino
acid starvation, in addition to inhibition ofmazEFG transcription
due to increased ppGpp, degradation of MazE will inactivate the
inhibition activity of the MazEF complex against the existing
MazG. Activation of MazG will deplete ppGpp levels, which in
turn causes re-transcription of mazEF to replenish MazE, which
consequently triggers the cells to emerge from their dormant state
(Gross et al., 2006).
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TABLE 1 | Solved type II toxin-antitoxin structures grouped according to the DNA-binding domain of the antitoxins.
DNA-binding
domain
Antitoxin Toxin Host organism Toxin-antitoxin complex
stoichiometries
References
HTH HipB HipA Escherichia coli HipB2HipA2 Schumacher et al., 2009
HipBSO HipASO Shewanella oneidensis (HipBSO)2(HipASO)2 Wen et al., 2014
MqsA MqsR E. coli MqsR-MqsA2-MqsR Brown et al., 2009, 2011
HigA HigB E. coli unknowna Arbing et al., 2010
HigA HigB Proteus vulgaris HigA2HigB2 Schureck et al., 2014
HigA2 HigB2 Vibrio cholerae Unknown Hadži et al., 2013
PezA PezT Streptococcus pneumoniae PezA2PezT2 Khoo et al., 2007
RHH RelB RelE E. coli RelB2RelE2 Bøggild et al., 2012
RelB RelE Methanococcus jannaschii RelB2RelE2 Francuski and Saenger, 2009
DinJ YafQ E. coli DinJ2YafQ2 Liang et al., 2014; Ruangprasert et al.,
2014
ParD ParE E. coli plasmid RK2 ParD2
b Oberer et al., 2007
ParD1 ParE1 Caulobacter crescentus (ParD1)2(ParE1)2 Dalton and Crosson, 2010
CcdA CcdB E. coli F plasmid (CcdA37−72)(CcdB)2
(CcdA37−72)2(CcdB)2
Madl et al., 2006; De Jonge et al., 2009
HicB3 HicA3 Yersinia pestis (HicB3)4(HicA3)2 Bibi-Triki et al., 2014
FitA FitB Neisseria gonorrhoeae (FitA-FitB)4 Mattison et al., 2006
VapB3 VapC3 Mycobacterium tuberculosis (VapB3)2(VapC3)2 Min et al., 2012
VapB5c VapC5 M. tuberculosis (VapB553−86 )(VapC5) Miallau et al., 2009
VapB30 VapC30 M. tuberculosis (VapB30)2(VapC30)2 Lee et al., 2015
ω (regulator for ε-ζ, not
antitoxin)
Streptococcus pyogenes
pSM19035 tripartite TA
system ω-ε-ζ
ε2ζ2 for the TA complex; ω2 for the
regulator protein
Murayama et al., 2001; Meinhart et al.,
2003
SpoVT/AbrB MazE MazF E. coli MazF2-MazE2-MazF2 Kamada et al., 2003; Loris et al., 2003;
Zorzini et al., 2015
VapB2 VapC2 Rickettsia felis (VapC2)4(VapB2)2
(VapC2)4(VapC2)4
Maté et al., 2012
VapB VapC Shigella flexneri VapB4VapC4 Dienemann et al., 2011
Phd/YefMe Phd Doc E. coli phage P1 Doc-Phd2-Doc Arbing et al., 2010; Garcia-Pino et al.,
2010
YefM YoeB E. coli YefM2YoeB Kamada and Hanaoka, 2005
YefM YoeB M. tuberculosis unknownd Kumar et al., 2008
Unknownf aRelB aRelE Pyrococcus horikoshii OT3 (aRelB)2(aRelE)2 Takagi et al., 2005
Unknowng VapB15 VapC15 M. tuberculosis (VapB15)2(VapC15)2
(VapB15)(VapC15)2
Das et al., 2014
aStructure was only available for the HigA antitoxin (Arbing et al., 2010).
bStructure only solved for ParD in solution by NMR (Oberer et al., 2007).
cN-terminal region of VapB5 could not be modeled but predicted to be RHH motif (Miallau et al., 2009).
dTA complex possibly YefM2YoeB; only YefM was crystalized (Kumar et al., 2008).
eYefM was found to share structural similarity with the Phd antitoxin with strong conservation of the N-terminal DNA-binding domain, which are thus classified as having a Phd/YefM-like
fold (Arbing et al., 2010).
fDNA-binding domain unclear, potentially leucine zipper dimerization with N-terminal basic residues used for DNA recognition (Takagi et al., 2005).
gN-terminal residues of VapB15 could not be modeled into the electron density (Das et al., 2014).
Two promoters, which are located 13 nucleotides apart, have
been identified upstream of the mazEFG operon (Figure 2A).
The P2 promoter is about 10-fold stronger than the P3 promoter
(Marianovsky et al., 2001). Expression of both promoters is
repressed by MazE and highly repressed with the MazEF
complex. Within the promoters lies an unusual fragment termed
the “alternating palindrome.” This alternating palindrome, which
is the operator of mazEFG, could exist in one of two alternative
states: its middle part designated “a,” complements either the
downstream fragment “b” or upstream fragment “c” (Figure 2A).
Binding of the MazEF complex to either arm of this alternating
palindrome will strongly repress the transcription of the mazEF
operon. The numerous mutations that were introduced into this
alternating palindrome did not affect the binding efficiency of
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FIGURE 1 | Three-dimensional structures showing the most frequent DNA-binding domains found in prokaryotic type II antitoxin proteins. The most
frequent DNA-binding domains found in type II antitoxins include: (A) the HTH-motif (of which the smallest structural motif is shown) that has two α-helices (red)
connected by a small loop (green); (B) the RHH folding motif, in which the minimal structure (as the one depicted corresponding to the CopG transcriptional repressor)
is generated by two antiparallel β-strands (arrows, with arrowheads pointing to the C-terminal part of the protomer) that generate a ribbon; each strand comes from
one of two protein monomers and they are involved both in dimer formation and in specific interactions with the DNA bases in the antitoxin DNA target (adapted from
Gomis-Rüth et al., 1998), and (C) the SpoVT/Abr DNA binding motif in which the dimeric molecules are constructed by three- and four-stranded antiparallel β-sheets
(upper part of the molecule) that are tightly packed, generating the DNA-binding domain. Loops keeping the outer part of the molecules are indicated by light green
and red colors.
the MazEF complex, suggesting that the secondary structure of
this regulatory region is more important than its DNA sequence
(Marianovsky et al., 2001). MazE has higher binding affinity for
fragment “a” than “b” or “c”.
Determination of the three-dimensional structure showed
that the MazE homodimer binds into the major groove of DNA
fragment “a,” involving the side-chains of residues Trp-9, Asn-
11, and Arg-16 for the main interactions with the oligonucleotide
(Figure 2B; Zorzini et al., 2015). Mobility shift assay with
titration of MazF showed that MazF could increase the affinity
of MazE for a single operator site where the concentration of
MazE itself is not sufficient to cause a band-shift. Superposition
of MazE-DNA complex on the crystal structure of the MazE-
MazF complex demonstrated that the interaction between DNA
and protein increased through the flanking basic regions of
the MazF homodimer. This indicates that the augmentation of
DNA binding by MazF is due to cooperative binding of the
antitoxin and toxin to the DNA instead of an allosteric effect.
However, reduced band-shift corresponding to the complex was
observed after a peak with increasing MazF, and the affinity
of MazE for binding to the “a” fragment is abolished at very
high ratio of MazF:MazE (Zorzini et al., 2015). This resembles
the conditional cooperativity phenomenon that was observed
in other TA systems like ccdAB, phd-doc, and relBE whereby
the expression of the TA operon is modulated by ratios of
antitoxin:toxin (Overgaard et al., 2008; De Jonge et al., 2009,
2010; Garcia-Pino et al., 2010).
Besides having two promoters and an unusual alternating
palindrome as operator site, the regulation of mazEF is also
governed by another positive regulation mechanism. Further
upstream of the alternating palindrome is a binding site for the
factor for inversion stimulation (FIS), which positively regulates
the transcription ofmazEF operon (Marianovsky et al., 2001). FIS
is a homodimer that binds and introduces bends in the DNA,
thereby increasing the binding efficiency of RNA polymerase
(Pan et al., 1996). The cellular level of FIS varies (up to 100-fold),
depending upon the growth phase and nutritional conditions of
the cells. The concentrations of FIS are highly elevated in the early
exponential phase but sharply declined toward the stationary
phase (Marianovsky et al., 2001), indicating positive regulation
of mazEF is maximal at rich medium during exponential phase.
Thus, the complex regulatory mechanism which combines two
promoters, alternating palindromes, the FIS-binding activation
site, concentrations of ppGpp and MazG, as well as the ratio
and the co-operative binding activities of the MazE and MazF to
the operator enables the expression of mazEF to become more
dynamic and to ensure a prompt response to cope with various
stresses or changes in the environment (Marianovsky et al., 2001).
An interesting dimension to the regulation of the MazF
toxin was reported recently whereby infection of E. coli with
bacteriophage T4 led to the addition of an ADP-ribosyl group to
MazF (Alawneh et al., 2016). This chemical modification of MazF
was catalyzed by phage T4-encoded Alt ADP-ribosyltransferase
which transfers an ADP-ribosyl group from nicotinamide
adenide dinucleotide (β-NAD+) to the Arg-4 residue of MazF,
resulting in partial reduction of MazF cleavage activity in vitro.
This inferred that phage T4 may harbor a unique antitoxin to
inactivate MazF during T4 infection and MazF could function as
an anti-phage mechanism in its E. coli host (Alawneh et al., 2016;
Otsuka, 2016). The biological significance of the T4-dependent
ADP-ribosylation of MazF and its effects on the existing mazEF
regulatory circuit awaits further investigations.
REGULATION VIA CONDITIONAL
COOPERATIVITY OF THE phd-doc, relBE,
AND kis-kid LOCI
Phd-Doc is a TA system found on bacteriophage P1 (Lehnherr
et al., 1993). The regulation of the phd-doc TA operon relies on
the stoichiometries of the Phd antitoxin and the Doc toxin, which
is a phenomenon called conditional cooperativity, as mentioned
above. Like other TAs, the Phd antitoxin has an intrinsically
disordered C-terminus that forms an α-helix upon binding to
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FIGURE 2 | The E. coli-encoded MazEF TA system. (A) Genetic organization of the E. coli mazEF operon, and the regulatory elements on the mazEF promoter.
Black arrows denote the transcriptional start sites of promoters P2 and P3. The stop codon of RelA and the start codon of MazE are underlined in brown. The FIS
binding site is indicated with a blue line. Alternating palindromic regions “c-a” or “a-b” are indicated with red arrows. Adapted and modified from Marianovsky et al.
(2001). (B) Structure of the MazE1−50 antitoxin homodimer-DNA complex (PDB accession: 2MRU). The MazE1−50 homodimer is indicated in blue and purple with the
operator DNA indicated in orange. The N- and C-termini of the two MazE1−50 units are as labeled. The key amino acid residues of MazE that are involved in binding
to the major groove of the double-stranded “a” operator DNA, i.e., Trp-9, Asn-11, and Arg-16 (Zorzini et al., 2015), are shown for one of the MazE monomers (blue).
the Doc toxin (Garcia-Pino et al., 2008). The N-terminal domain
of the Phd antitoxin is a dimerization domain that binds to the
DNA operator to repress phd-doc expression. Doc toxin, which
impedes translation by phosphorylating the conserved Thr-382
residue on elongation factor EF-Tu (Castro-Roa et al., 2013;
Cruz et al., 2014), can also serve as a corepressor or derepressor
depending on the molar ratio of both Doc and Phd proteins
(Garcia-Pino et al., 2010). A monomeric Doc toxin has two
binding sites that are able to interact with two Phd dimers, with
different affinities, bridging the Phd dimers to bind more avidly
to the operator. However, saturation of Doc toxin will be in favor
of the high-affinity sites (H sites), outcompeting the low-affinity
sites (L-sites) by Phd. This results in the restructuring of the
repressor-corepressor complex to an alternative non-repressing
Doc-Phd2-Doc complex, which cannot bind to the operator
DNA due to steric reasons (Liu et al., 2008; Arbing et al., 2010;
Garcia-Pino et al., 2010). Thus, the stoichiometry of Phd:Doc
complex is important in modulating the regulation of phd-doc
operon.
The relBE operon is one of the most prevalent and best-
characterized TA system that was originally discovered on the
chromosome of E. coli (Gotfredsen and Gerdes, 1998). The RelE
toxin does not target free mRNA but cleaves mRNA in the
ribosomal A site with codon specificity (Christensen and Gerdes,
2003). The RelB antitoxin neutralizes the toxic activity of RelE
by displacing the α4 helix, thereby disrupting the geometry of
the critical catalytic residues of the free RelE structure. RelB
dimers bind to the operator through a RHHmotif to autoregulate
transcription (Overgaard et al., 2009). However, the affinity of
RelB binding to DNA is relatively low, and addition of RelE up
to a ratio of 2 RelB: 1 RelE drastically enhanced the binding
affinity (Christensen-Dalsgaard et al., 2008; Overgaard et al.,
2008). The RelB2RelE heterotrimer complexes bind strongly and
cooperatively to the promoter to repress transcription. When
RelE is in excess, an unusual V-shaped structure is formed, with
two RelE bound at the distant ends of the RelB dimer. These
heterotetramer complexes will clash when two RelB dimerization
domains bind adjacently to the DNA, which leads to the complex
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falling-off from the operator DNA and derepressing transcription
(Bøggild et al., 2012). The destabilization of the RelB2RelE
complex from the DNA can be due to “stripping,” in which the
excessive free toxin molecules invade the RelB2RelE heterotrimer
complex; or the bulk formation of RelB2RelE2 heterotetramer
complexes that sequester the heterotrimer complex (Cataudella
et al., 2012). During normal cellular growth, relB has higher
rate of translation than relE, leading to tenfold more RelB than
RelE protein molecules (Overgaard et al., 2009). Binding of the
RelB2RelE heterotrimer will repress transcription of relBE to a
minimal level. When cells undergo nutritional stress, since the
lifetime of RelB is 10-fold shorter than RelE (Overgaard et al.,
2009), the labile RelB will be degraded more rapidly by Lon
proteases and this subsequently increases the RelE:RelB ratio.
Consequently, more RelB2RelE2 heterotetrameric complexes are
formed that eventually derepress the repression of the relBE
operon to replenish RelB levels in the cell. This conditional
cooperativity of RelBE has also been shown to facilitate the fast
recovery of cells from RelE-mediated reduction in translation
when the nutritional stress is removed (Cataudella et al., 2012).
In the case of the RelBE2Spn operon from S. pneumoniae,
the interaction of the two proteins with the DNA target
was approached by means of band-shift, analytical
ultracentrifugation, and native mass spectroscopy. The results
led to the conclusion that the stoichiometry of the RelB2Spn
antitoxin in complex with its DNA target and of the RelBE2Spn
protein-protein complex was compatible with a heterohexamer
composed of four antitoxin and two toxin protein molecules, in
both conditions: protein-protein and protein-DNA complexes
(Moreno-Córdoba et al., 2012).
The parD operon of plasmid R1 from E. coli encodes the
Kis-Kid TA (Bravo et al., 1988). Kid toxin is a ribonuclease
that preferentially cleaves single stranded RNA at the 5′of the
adenosine residue of sequence 5′-UA(A/C)-3′. However, cleavage
at 3′of the adenosine residue on double stranded RNA was
also evident (Pimentel et al., 2005; Kamphuis et al., 2006).
Besides hindering the toxic effect of Kid toxin, Kis antitoxin
is also a weak repressor that binds to its own promoter
to regulate the transcription of parD. Like other typical TA,
Kid toxin does not bind to the promoter but acts as a co-
repressor. There are two binding regions where Kis dimers,
but not monomers, preferentially bind to region I compared to
region II (Figure 3). Region I harbors a perfect palindrome that
overlaps the −10 consensus region of the promoter, whereas
region II is an imperfect palindrome that is located upstream
of the −35 sequence (Kamphuis et al., 2007b). Differential
molar ratios of Kis and Kid can result in multiple complexes
of Kis-Kid with different stoichiometries and oligomeric states
(Monti et al., 2007). When Kid toxin is in excess, Kid2-Kis2-
Kid2 hexamer, which has weak affinity to parD DNA, is most
abundant. Conversely, when the Kis antitoxin equals or exceeds
the concentration of the Kid toxin, strong cooperative effect will
form between parD DNA and Kid2-Kis2-Kid2-Kis2 octamers.
The Kis-Kid octameric complex can bind to the two half-sites of
parD DNA region I and II with two dimers of the Kis antitoxin.
However, the Kis-Kid hexamer can only bind to the two half-sites
using one dimer, which thus explains its weak affinity (Figure 3
Kamphuis et al., 2007a,b; Monti et al., 2007; Diago-Navarro et al.,
2010). Therefore, the cooperative binding between region I and
region II with the Kis-Kid octamer plays an important role in
the transcription regulation of the parD operon, and this is
dependent critically on the molar ratios of Kis and Kid.
THE HYBRID YefM-YoeB TA SYSTEM:
FURTHER COMPLEXITIES IN TA
REGULATION
Toxins of type II TA systems have been divided into 12
superfamilies whereas type II antitoxins have been classified into
20 superfamilies based on sequence similarities (Leplae et al.,
2011). Toxins and antitoxins from different families can associate
and form hybrid systems (Arbing et al., 2010; Leplae et al., 2011),
with the yefM-yoeB locus of E. coli being one such example.
The YefM antitoxin is from the Phd superfamily whereas the
YoeB toxin belongs to the ParE/RelE superfamily; the canonical
association would be Phd-Doc and RelB-RelE (Połom et al.,
2013). YefM-YoeB was identified as a potential TA system based
on sequence similarities of YefM with the Phd antitoxin of phage
P1 (Pomerantsev et al., 2001) and homology with the axe-txe
TA system of Enterococcus faecium plasmid pRUM (Grady and
Hayes, 2003). Ectopic overexpression of YoeB was shown to
be toxic to E. coli but YefM counteracted this toxicity (Grady
and Hayes, 2003). Since then, the yefM-yoeB TA system has
been found in diverse bacterial species including S. pneumoniae
(Nieto et al., 2007; Chan et al., 2011), Streptococcus suis (Zheng
et al., 2015), M. tuberculosis (Kumar et al., 2008), Staphylococcus
aureus (Yoshizumi et al., 2009), Staphylococcus equorum (Nolle
et al., 2013), Lactobacillus rhamnosus (Krügel et al., 2015), and
Streptomyces (Sevillano et al., 2012).
The E. coli-encoded YoeB toxin binds with the 70S ribosome
with both the 30S and 50S subunits participating in YoeB
binding and cleaves mRNA at the second position of the
A site codon, thus inhibiting translation initiation in E. coli
(Kamada and Hanaoka, 2005; Feng et al., 2013). YefM-YoeB
forms a heterotrimeric YefM2-YoeB complex where one C-
terminal peptide of the YefM dimer binds with YoeB while the
other projects into the solvent (Figure 4A). The YefM dimer
has symmetrical N-terminal globular structure while the C-
terminus of YefM appears to be structurally disordered in the
absence of YoeB and undergoes a disorder-to-order transition
upon YoeB binding (Kamada and Hanaoka, 2005). YoeB forms
a compact globular structure with structural similarities in its
active site to RelE and other microbial RNases. Binding of YoeB
to YefM in the heterotrimeric complex leads to conformational
rearrangement of the RNase catalytic site of YoeB and direct
obstruction by YefM, thus suppressing the toxicity of YoeB
(Kamada and Hanaoka, 2005). The crystal structure of the YefM
antitoxin from M. tuberculosis also indicated an ordered N-
terminal domain and a very flexible C-terminal end that adopts
different conformations in different monomers. This flexibility is
postulated to make YefM more prone to proteolytic degradation
(Kumar et al., 2008). YoeB-dependent mRNA cleavage is
indeed activated by overproduction of the Lon protease in E.
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FIGURE 3 | Stoichiometries of Kis-Kid complexes and their binding affinities to parD DNA. When the Kis antitoxin is in excess, or in equal amounts as Kid
toxin, various Kis-Kid complexes are formed (e.g., [kid2-Kis2]n or [kid2-Kis2-kid2-Kis2]n etc.). The most abundant one, the Kid2-Kis2-Kid2-Kis2 octamer complex,
binds strongly to the two half-sites of the parD DNA regions I and II with two Kis dimers, and thus strongly represses the transcription of parD operon. When the Kid
toxin exceeds Kis antitoxin, the Kid2-Kis2-Kid2 hexamer is the most abundant. The Kid2-Kis2-Kid2 hexamer has weak affinity toward parD DNA as it can only bind to
the two half-sites of regions I and II using one dimer. Adapted and modified from Diago-Navarro et al. (2010).
coli, suggesting that Lon is responsible for YefM degradation
(Christensen et al., 2004).
Like most type II TA systems, the E. coli yefM-yoeB locus is
transcriptionally autoregulated with YefM being the repressor
and YoeB being a co-repressor that enhances the transcriptional
repression (Kedzierska et al., 2007). There are no conventional
DNA-binding motifs apparent in YefM but the N-terminal
domains of the YefM dimer in the YefM2 YoeB trimeric complex
display conserved basic patches below the symmetrical dimer
interface and this was suggested as the primary DNA anchor
for operator site binding (Kamada and Hanaoka, 2005; Bailey
and Hayes, 2009). Two arginine residues within this basic patch
(R10 and R31) were mutated and found to be essential for DNA
binding by the YefM2 YoeB complex (Bailey and Hayes, 2009).
Thus, a novel protein fold likely mediates operator recognition
by YefM and we will have to await the elucidation of the YefM
and YefM-YoeB structures bound to DNA for affirmation. The
operator site in the E. coli yefM-yoeB locus consists of short (S)
and long (L) palindromes, both of which possess a core hexameric
5′- TGTACA-3′ motif. The center-to-center distance between the
L and S palindromes are 12 bp with the L palindrome overlapping
the −10 promoter region (Figure 4B). YefM initially binds to
the L palindrome followed by the S palindrome (Kedzierska
et al., 2007). Changing the spacing between the two palindromes
perturbs the cooperative binding of YefM-YoeB to the repeats
whereby binding to the L repeat is maintained but binding to
the S repeat is disrupted (Bailey and Hayes, 2009). The L and
S palindromes appeared to be conserved in regions upstream
of yefM-yoeB homologs from several bacterial genomes such as
Shigella boydii, Pseudomonas aeruginosa, and Erwinia carotovora
(Kedzierska et al., 2007) inferring that interaction of the YefM-
YoeB homologs with these motifs could be a conserved mode
of transcriptional autoregulation in these operons (Hayes and
Kêdzierska, 2014).
However, investigations into the regulation of the yefM-yoeB
locus in S. pneumoniae, designated yefM-yoeBSpn, indicated a
different and more complex regulatory mechanism (Chan et al.,
2011). Expression of the yefM-yoeBSpn locus is driven by two σ70-
type promoters 30 bp apart: PyefM2, which is closer to the yefM-
yoeBSpn genes and PyefM1, which lies further upstream to PyefM2
(Figure 4C). The hexameric 5′-TGTACA-3′ motif (Kedzierska
et al., 2007) is also found within the pneumococcal yefM-yoeBSpn
promoter region with one of the motifs being part of a longer
44 bp incomplete palindrome sequence that overlapped the
−35 region of PyefM2 (Figure 4C) and which was shown by
footprinting experiments to be the operator site for the operon
(Chan et al., 2011). PyefM2 is likely the native promoter for yefM-
yoeBSpn as its expression is autoregulated like other canonical
type II TA systems, i.e., YefMSpn represses transcription from
PyefM2 while YoeBSpn exerts further repression in complex with
YefMSpn. However, PyefM1 appeared to be a constitutive, weaker
promoter as compared to PyefM2 and is not regulated by YefM-
YoeBSpn (Chan et al., 2011). Interestingly, the PyefM1 promoter
came about from insertion of a BOX element upstream of PyefM2
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FIGURE 4 | The YefM-YoeB TA systems from E. coli and S. pneumoniae. (A) Tertiary structure of the E. coli YefM2 YoeB heterotrimeric complex (PDB
accession: 2A6Q). The YefM homodimer is indicated in yellow and green with the monomeric unit containing the disordered C-termini in yellow whilst the other unit
with the ordered C-termini that binds to the YoeB monomer (shown in red) is depicted in green. The N- and C-termini of the two YefM units are indicated in their
respective colors. (B) Sequence and organization of the upstream regulatory region of the E. coli yefM-yoeB locus. The −10 and −35 regions of the promoter are
shown in blue boxes, the core hexameric 5′-TGTACA-3′ sequence is indicated in green bold letters, and the long (L) and short (S) palindromic sequences are denoted
by inverted green arrows. A red asterisk denotes the transcription start site. (C) Sequence and organization of the upstream regulatory region of the S. pneumoniae
yefM-yoeBSpn locus. The −10 and −35 regions of the two promoters PyefM1 and PyefM2 are shown in blue boxes. The imperfect palindrome sequence, PS, that is
the operator site for PyefM2 is indicated by inverted purple arrows whereas the hexameric 5
′-TGTACA-3′ sequence is underlined. Sequences that are part of the BOX
element are depicted in orange letters. Red asterisks denote the transcription start sites from PyefM1 and PyefM2.
and more intriguingly, transcriptional activation was observed
when the BOX element, PyefM1, PyefM2, and yefMSpn were all in
cis (but not when yefMSpn was provided in trans), hinting at
the possible involvement of other hitherto unknown cis-acting
factors in the regulation of the yefM-yoeBSpn locus (Chan et al.,
2011). BOX elements are enigmatic sequences, considered to be
potentially mobile and distributed randomly in numerous copies
in the intergenic regions of pneumococci and related species.
The occurrence and placement of the BOX element seems to be
conserved in all S. pneumoniae strains that harbor yefM-yoeBSpn,
suggesting its likely evolutionary importance to the biological
function of yefM-yoeBSpn in pneumococci (Chan et al., 2011,
2012).
A BOX-like element was also found upstream of the yefM-
yoeBLrh locus of L. rhamnosus but unlike in S. pneumoniae,
this insertion did not lead to the creation of an additional
promoter (Krügel et al., 2015). Nevertheless, the regulation of
the yefM-yoeBLrh locus appeared to be complex as well with
two transcription start sites detected within the yefMLrh gene
besides the main transcript that is expressed from a σ70-type
promoter upstream of yefMLrh. Furthermore, the expression
levels of yefMLrh and yoeBLrh differed during various stages of
growth and environmental stresses and appeared to respond
differently in different L. rhamnosus strains (Krügel et al., 2015).
The surprising discovery of a short transcript that is divergently
transcribed and overlaps the yoeBLrh gene and with similarities
to several type I antitoxins also hints at further complexity of the
yefM-yoeBLrh operon regulation in L. rhamnosus (Krügel et al.,
2015).
Such complex and multilayered regulatory control was also
observed for the yefM-yoeB homolog, axe-txe, found in the E.
faecium plasmid pRUM (Boss et al., 2013). The main promoter,
pat, is autoregulated like other type II TA systems with the Axe
antitoxin repressing the promoter weakly and stronger repression
with the Axe-Txe TA complex. However, an internal promoter
within the axe gene also directs the expression of the downstream
txe toxin gene and this promoter did not appear to be regulated
by Axe-Txe. Nevertheless, this internal promoter is crucial for
axe-txe to function as a plasmid stabilization module, suggesting
that it plays a role in setting the appropriate Axe:Txe ratio for
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proper functioning of the system (Boss et al., 2013). The finding
of a cryptic transcript that originates within the txe reading frame
along with a putative transcription terminator-like sequence
downstream of txe that possibly modulates production of Txe are
indicative of further complexities in the regulation of the axe-txe
operon (Boss et al., 2013; Hayes and Kêdzierska, 2014).
THE MqsA ANTITOXIN OF THE mqsRA TA
LOCI: AN ANTITOXIN THAT ALSO
REGULATES OTHER GENES
The MqsRA locus of E. coli K-12 is an unusual TA locus that
differs from most canonical TA systems. The MqsR (motility
quorum sensing regulator) toxin was initially identified as
a regulator of motility and quorum sensing, influencing the
development of biofilms by mediating the cellular response to
autoinducer-2 (Ren et al., 2004; González Barrios et al., 2006).
ThemqsR gene was also significantly upregulated in persister cells
and, along with its downstream gene, mqsA, were shown to be
a type II TA system (Brown et al., 2009; Yamaguchi et al., 2009;
Christensen-Dalsgaard et al., 2010; Kasari et al., 2010). MqsR is a
ribosome-independent endoribonuclease that specifically cleaves
mRNA at 5′-GCU-3′ and, to a lesser extent, 5′-GCA-3′ sequences
(Yamaguchi et al., 2009; Christensen-Dalsgaard et al., 2010).
The MqsRA system is unique in several aspects. The mqsR
toxin gene precedes the mqsA antitoxin gene, an arrangement
that so far has been observed only in a few type II TA loci,
namely higBA (Tian et al., 1996), hicAB (Jørgensen et al., 2009),
and rnlAB (Koga et al., 2011). The MqsA antitoxin is larger
than MqsR toxin (14.7 kDa and 11.2 kDa, respectively) whereas
in canonical TA systems, the toxin is larger than the antitoxin,
with the exception of HicB (Jørgensen et al., 2009). Both MqsA
and MqsR are also basic proteins whereas usually, the toxin is
basic while the antitoxin is acidic (Kasari et al., 2010).
Elucidation of the MqsRA crystal structure also revealed
a few surprises. The MqsRA complex is a dimer of dimers,
comprising of two copies of MqsR and two copies of MqsA
(Brown et al., 2009). The MqsA antitoxin monomer is well-
ordered throughout its entire length and is composed of two
structurally-distinct domains connected by a flexible linker which
enables the two domains to rotate independently of each other
(Brown et al., 2009). The N-terminal domain of MqsA binds
zinc via coordination with four conserved cysteine residues
with the bound zinc serving as a structural and not a catalytic
role (Figure 5). MqsA interacts with DNA mainly through its
C-terminal HTH domain that is also responsible for MqsA
dimerization (Brown et al., 2009). Most antitoxins interact with
DNA through their N-terminal residues with the exception of
HicB (Hayes and Kêdzierska, 2014). However, MqsA binding
to DNA leads to bending of the DNA by more than 55◦ as
well as a rotation of the N-terminal domain by more than
105◦. This changes MqsA from a highly extended conformation
into a narrow, elongated DNA “clamp” as a result of the
formation of a DNA-binding pocket which positions several
MqsA N-terminal residues (Phe-22, Arg-23, Lys-58, and Arg-
61) for DNA interaction (Figure 5; Brown et al., 2011). Such
conformational change is unprecedented for a bacterial antitoxin.
The neutralization of MqsR toxicity by MqsA is through steric
occlusion and not by direct binding of the toxin active site as
in many other antitoxins. Formation of a MqsR-MqsA-DNA
complex induces substantial conformational changes (Yamaguchi
et al., 2009) whereby the MqsR active site residues Lys-56, Gln-
68, Tyr-81, and Lys-96 face inwards and toward the other MqsR
toxin pair with a separation of only 13–15 Å (Brown et al., 2011).
This severely limits the accessibility of the MqsR active sites for
mRNA.
Like most other type II antitoxins, the MqsA antitoxin
represses transcription of mqsRA but instead of acting as a
co-repressor, the MqsR toxin functions as a transcriptional
derepressor by disrupting the MqsA-DNA interaction. In fact, a
1:1 ratio of MqsR to MqsA ablated MqsA-DNA binding due to
partial overlapping of binding sites on MqsA (in particular, the
Arg-61 residue) for both MqsR and DNA (Brown et al., 2013).
Another unique aspect of the MqsA antitoxin is that it serves not
only as a transcriptional regulator of its own mqsRA locus but
also of several other E. coli genes including mcbR, cspD, spy and
the general stress response sigma factor rpoS (Brown et al., 2009;
Kim et al., 2010; Wang et al., 2011). An mqsRA-like palindromic
operator site is found upstream of rpoS (Wang et al., 2011) and
csgD, which encodes a master regulator of biofilm formation
through the control of curli (thin proteinaceous amyloid fibers
which is a major extracellular component that promotes biofilm
formation) and cellulose production (Soo and Wood, 2013).
FIGURE 5 | Structure of the E. coli MqsA-DNA complex. Tertiary structure
of the E. coli-encoded MqsA dimer in complex with its operator DNA (PDB
accession: 3O9X). The monomers of the MqsA dimer are colored either in
green or in blue with their N- and C-termini indicated in their respective colors;
zinc ions are shown as gray spheres; the mqsRA operator DNA is depicted in
orange. For clarity, the MqsA amino acid residues that are crucial for interaction
with operator DNA (Phe-22, Arg-23, Lys-58, and Arg-61) are shown for only
one of the monomers as are the cysteine residues (Cys-3, Cys-6, Cys-37, and
Cys-40) involved in coordination with the zinc ion (Brown et al., 2011).
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CsgD also transcriptionally activates the gene for diguanylate
cyclase (AdrA) which synthesizes the secondary messenger 3,5-
cyclic diguanylic acid (c-di-GMP). Levels of c-di-GMP controls
the switch from motility (low c-di-GMP) to sessility (high c-
di-GMP) of E. coli (Soo and Wood, 2013). When nutrients are
plentiful, MqsA increases motility by increasing the expression of
flhD, the master regulator of E. coli motility partly through rpoS
inhibition and partly through csgD inhibition, which also leads
to low levels of c-di-GMP. Thus, in the absence of stress, MqsA
functions to inhibit biofilm formation. When E. coli is under
stressful conditions, Lon protease degrades MqsA, activating
the MqsR toxin. Degradation of MqsA leads to derepression of
rpoS and csgD, inhibition of flhD, high levels of c-di-GMP and
subsequently, increased biofilm formation (Wang et al., 2011; Soo
and Wood, 2013).
The MqsRA system was also recently shown to control the
type V TA system, GhoST (Wang et al., 2013). The MqsR toxin
enriches the ghoT toxin mRNA as the transcript lacks the MqsR
cleavage site, 5′-GCU. GhoT functions as a membrane toxin
that produces the phenotype known as ghost cells (lysed cells
with damaged membranes; Wang et al., 2012). Under stressful
conditions, MqsR is freed and the toxin degrades mRNAs
primarily at 5′-GCU sites suc h as the 5′-end of the ghoST mRNA
within the ghoS antitoxin coding sequence (which contains three
5′-GCU sites) but not ghoT. This leads to higher levels of GhoT
toxin, which exerts its effects on the cell membrane, ultimately
increasing persistence (Wang et al., 2013). Thus, there appears
to be a hierarchy of TA systems in E. coli cells in which MqsRA
controls GhoST.
TRANSCRIPTIONAL ACTIVATORS THAT
FUNCTION AS ANTITOXINS: THE TALE OF
THE MrpC REGULATOR AND THE
SOLITARY MazF TOXIN OF MYXOCOCCUS
XANTHUS
Myxococcus xanthus is a Gram-negative, rod-shaped
bacterium that provides a prokaryotic model for multicellular
developmental processes. Under nutrient starvation conditions,
cells form aggregates which mature into fruiting bodies with
some cells differentiating into spores. Other cells remain outside
the fruiting bodies as persister-like cells termed peripheral rods
whereas the majority of cells lyse during this developmental
process (Nariya and Inouye, 2008; Lee et al., 2012; Robinson
et al., 2014). The M. xanthus genome was found to encode a
solitarymazF toxin gene,mazF-mx, without a cognatemazE-like
antitoxin gene (Nariya and Inouye, 2008). The mazF-mx gene
was found to be developmentally regulated and deletion of
mazF-mx in M. xanthus DZF1 reduced developmental cell lysis,
produced a severe delay in aggregation and reduced sporulation.
Interestingly, it was reported that MrpC, which is an essential
developmental transcription factor, was found to regulate the
expression of mazF-mx and also functions as an antitoxin
for MazF-mx by forming a stable complex with MazF-mx
(Nariya and Inouye, 2008). The mrpC gene is encoded 4.44 Mbp
downstream from mazF-mx and activates expression of many
development-specific genes with strains lacking mrpC failing
to develop and sporulate. Severe cell toxicity by MazF-mx was
observed in a 1mrpC mutant when mazF-mx expression was
induced (Nariya and Inouye, 2008). It was thus proposed that
the orphan mazF-mx in M. xanthus was successfully integrated
into the cellular developmental programme with another
transcription factor unrelated to the common cognate MazE
antitoxin functioning as the surrogate antitoxin.
However, some apparently conflicting data have recently
emerged regarding the MazF-mx function. Lee et al. (2012)
showed that deletion of mazF-mx from the wild-type strains
DK1622 and DZ2 had minimal to no effect on developmental
cell lysis and sporulation as opposed to its deletion in strain
DZF1 as reported by Nariya and Inouye (2008). It was postulated
that the DZF1 background contains a pilQ1 allele bearing two
missense mutations in pilQ (G741S and N762G) which greatly
sensitizes M. xanthus cells and render them more susceptible to
lysis (Lee et al., 2012). Indeed, it was shown that the phenotypic
effects of mazF-mx removal in DZF1 were recreated in strain
DK1622 by introducing the pilQ1mutation into a1mazFmutant
(Boynton et al., 2013). Lee et al. (2012) proposed the existence of
two parallel, redundant pathways of developmental programmed
cell death in DK1622 and DZ2, one of which is controlled by
MazF-mx, and the other by an unknown mechanism which was
disrupted in strain DZF1. However, Boynton et al. (2013) raised
the possibility that the observed phenotypic differences may
be artifactual, resulting from increased membrane permeability
due to the pilQ1 allele. Further, Boynton et al. (2013) reported
that MrpC enhanced MazF-mx endoribonuclease activity in
direct contrast to the inhibitory antitoxin behavior reported by
Nariya and Inouye (2008) leading to a model in which MazF-
mx was postulated to function without an antitoxin partner.
Thus, MazF-mx seems to have elicited a scientific conundrum
reminiscent of the cell death vs. cell stasis debate that erupted
for the E. coli-encoded MazEF system more than a decade
ago (Christensen et al., 2003; Gerdes et al., 2005; Engelberg-
Kulka et al., 2006; Kolodkin-Gal et al., 2007; Van Melderen and
Saavedra De Bast, 2009; Van Melderen, 2010). We await further
experimental evidences and scientific arguments that will be
presented regarding this topic.
TRIPARTITE TYPE II TA LOCI
The pas (plasmid addiction system) found in the 12.2 kb
broad-host range, mobilizable plasmid pTF-FC2 from
Acidithiobacillus ferroxidans (formerly Thiobacillus ferroxidans)
was a curious example of a type II TA system with three
components, the PasA antitoxin, the PasB toxin, and PasC
(Figure 6), a third component that appeared to enhance the
ability of the PasA antitoxin to neutralize the PasB toxin (Smith
and Rawlings, 1997, 1998b; Rawlings, 1999). The pas locus is
autoregulated with PasA as the transcriptional repressor and
PasB as the co-repressor. Full repression of the pas promoter
was observed with the PasAB complex whereas PasC did not
appear to play any regulatory role (Smith and Rawlings, 1998a).
A similar plasmid, pTC-F14 from Acidithiobacillus caldus,
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FIGURE 6 | Genetic organization of tripartite type II TA systems. The
tripartite TA systems depicted here are the pasABC TA system of plasmid
pTF-FC2 from A. ferroxidans (Smith and Rawlings, 1997), the ω-ε-ζ TA system
of plasmid pSM19035 from S. pyogenes (Cegłowski et al., 1993), the
paaR2-paaA2-parE2 system from E. coli O157:H7 (Hallez et al., 2010), and the
spoIIS TA system from B. cereus (Melnicˇáková et al., 2015). The antitoxin gene
is depicted as blue arrows, the toxin gene as red arrows, the regulatory or third
component gene as yellow arrows while gray arrows are for surrounding
non-TA genes. Black line arrows indicate the relevant promoters for each TA
system with the weaker Pε promoter (in comparison to the Pω promoter)
shown as a dotted arrow. Note that the diagram is not drawn to scale.
harbors only pasA and pasB and it was found that the two-
component pasAB from pTC-F14 was less efficient at stabilizing
a heterologous, low-copy tester plasmid pOU82 in E. coli when
compared to the three-component pasABC of pTF-FC2 (Deane
and Rawlings, 2004). Perhaps PasC forms a complex along with
PasAB to augment the PasA antitoxin in neutralizing PasB. PasC
can indeed be expressed along with PasA and PasB in E. coli
(Smith and Rawlings, 1997) but there has yet to be any published
reports on whether such a PasABC protein complex does occur.
Hence, the actual function of PasC and how it helps PasA to
abrogate the lethality of PasB remains unknown in the absence
of further experimental results.
Another tripartite type II TA system, theω-ε-ζ system that was
discovered encoded on the low-copy number plasmid pSM19035
from a clinical isolate of Streptococcus pyogenes (Figure 6),
differed from the pas locus in which the regulatory role is played
by a third party. In this TA system, both the ε antitoxin and the
ζ toxin have no roles in transcriptional regulation, the function
which is played instead by the ω regulator (de la Hoz et al., 2000;
Volante et al., 2014). ε-ζ is a type II TA system in which the
10 kDa ε antitoxin inactivates the 32 kDa ζ toxin through steric
occlusion. The crystal structure of the ε-ζ complex indicated a
heterotetrameric ε2ζ2 arrangement whereby the N-terminal of
ε sterically blocks the ATP-binding active site of ζ (Meinhart
et al., 2003). The mechanism of ζ toxicity is unique among
bacterial TA toxins whereby its target is the cell wall precursor
UDP-N-acetylglucosamine (UNAG) which is phosphorylated by
ζ to UDP-N-acetylglucosamine-3′-phosphate (UNAG-3P) using
ATP. UNAG is a basic unit of the peptidoglycan scaffold and
phosphorylation of UNAG by ζ converts it into a metabolite
unusable for peptidoglycan synthesis (Mutschler et al., 2011).
Besides that, UNAG-3P is also a competitive inhibitor of MurA,
the enzyme that catalyzes the first step in peptidoglycan synthesis.
Therefore, ζ functions to inhibit bacterial cell wall synthesis
(Mutschler andMeinhart, 2011; Mutschler et al., 2011). However,
a recent paper reported that expression of ζ only reduced
the UNAG pool and did not totally deplete it with transient
expression of ζ (120min) reversibly inducing a dormant state
that was subsequently rescued by ε expression (Lioy et al., 2012;
Tabone et al., 2014). It was proposed that ζ expression induces
diverse responses to cope with stress with reduction in the UNAG
levels as one of these responses rather than triggering a latent
suicide program by depleting the UNAG pool (Tabone et al.,
2014).
The ω-ε-ζ genes form an operon with two distinct promoters,
Pω upstream of the ω reading frame, and Pε, upstream of
the ε reading frame (Figure 6). Transcription mainly initiates
from the σ70-type Pω promoter whereas Pε appeared to be
a weak, constitutive promoter that contributes marginally to
transcription of the ε-ζ operon (de la Hoz et al., 2000).
The ω regulator belongs to the MetJ/Arc repressor family,
has an unstructured N-terminal domain followed by a RHH
DNA-binding motif (Murayama et al., 2001). The binding site
recognized by ω is distinctive, comprising of both palindromic
and non-palidromic heptad repeats (5′-NATCACN-3′) in the
operator site. A single ω2 dimer binds to one heptad repeat
and it was suggested that cooperative binding of the ω2
dimer is achieved by polymerization of ω2 on arrays of the
repeated heptad elements (Weihofen et al., 2006). ω also
functions as a global regulator for plasmid pSM19035, controlling
the expression of genes such as the copy control gene copS
and the plasmid partitioning gene δ, which encodes a ParA
ATPase. Interestingly, ω2 can either activate or repress Pω in a
concentration-dependent manner with δ2 acting as a co-activator
by increasing the half-life of the ω2.Pω DNA complexes (Volante
et al., 2015).
Another tripartite type II TA system, the paaR-paaA-parE
system, was identified in the genome of E. coli O157:H7
(Figure 6; Hallez et al., 2010). The ParE toxin is usually associated
with the ParD antitoxin (Gerdes et al., 2005). PaaA is a novel
antitoxin family that is associated with the ParE toxin, and
paaA-parE forms an operon with a third component, paaR that
functions as a transcriptional regulator. The paaR-paaA-parE
operon is co-transcribed from a σ70-type promoter upstream
of paaR (Hallez et al., 2010). Unlike the ω-ε-ζ system in
which ε-ζ did not play any role in transcriptional regulation
(Mutschler and Meinhart, 2013), the PaaA antitoxin forms a
complex with the ParE toxin that repress transcription from the
paaR promoter, albeit partially. Full repression of transcription
requires the PaaR regulator (Hallez et al., 2010). However, the
two repressor complexes (i.e., PaaA-ParE and PaaR) probably
act independently as no three-protein complexes were detected
under experimental conditions (Hallez et al., 2010). Interestingly,
the genome of E. coli O157:H7 contains two paralogous paaR-
paaA-parE systems with the second paaR2-paaA2-parE2 system
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located in a predicted prophage. Both systems apparently coexist
independently as the PaaA1 antitoxin is unable to neutralize
ParE2 toxicity and vice versa (Hallez et al., 2010).
A recent report regarding the SpoIIS TA system from Bacillus
cereus revealed a curious variation of the tripartite TA system
(Melnicˇáková et al., 2015). The spoIIS locus was initially identified
in B. subtilis and was then deduced to consist of two genes,
the spoIISA toxin-coding gene and the spoIISB antitoxin-coding
gene, i.e., a typical type II TA locus (Adler et al., 2001). However,
transcriptome analysis of B. subtilis had indicated the presence
of a third transcriptionally active region within the spoIIS locus
designated S458 (Nicolas et al., 2012) and which has been
renamed spoIISC (Melnicˇáková et al., 2015). Intriguingly, it was
discovered that spoIISC in B. subtilis as well as B. cereus coded
for an antitoxin that neutralizes the toxicity of SpoIISA. In
other words, the SpoIISA toxin is neutralized by two antitoxins,
SpoIISB and SpoIISC (Melnicˇáková et al., 2015). In a departure
from most type II TA systems, each gene in the spoIIS locus
is transcribed from its own promoter (Figure 6) and each
promoter is apparently transcribed under different conditions.
For example, in B. subitilis only spoIISA and spoIISB are
transcribed during nutrient deprivation, whereas during ethanol
stress, only the spoIISA is transcribed and spoIISC transcribed
during biofilm formation (Nicolas et al., 2012; Melnicˇáková et al.,
2015). This gives a hint at the complexity of the regulation of the
spoIIS locus that may necessitate the need for two antitoxins, each
of which could antagonize the toxicity of SpoIISA. However, at
this point, there is no information as to whether the expression
of the spoIIS genes is autoregulated.
CAVEATS: THE EzeT AND VapC-1 TOXINS
The ζ toxin of the tripartite ω-ε-ζ system has two types of
interesting chromosomally-encoded homologs. One homolog
is exemplified by the PezT toxin of the pezAT system of S.
pneumoniae whereby pezAT is a typical type II TA system in
which the antitoxin PezA also plays an autoregulatory role,
unlike the ε antitoxin (Khoo et al., 2007). PezA contains an
N-terminal HTH DNA-binding motif as its repressor domain,
which is fused with the three-helix bundle domain that binds
and inhibits the PezT toxin. In this instance, no homologs of
the ω regulator is evident in the S. pneumoniae genome (Khoo
et al., 2007) and it is clear that ω and the repressor domain
of PezA have different evolutionary origins. It was postulated
that pezA likely originated from a fusion event of an unrelated
transcriptional repressor coding sequence to the 5′-end of the
coding sequence of an ε ortholog (Mutschler and Meinhart,
2013). Hints of involvement of PezAT in the pathogenicity of S.
pneumoniae and its function in the pneumococcal pathogenicity
island 1 (Brown et al., 2004; Harvey et al., 2011; Mutschler and
Meinhart, 2011; Chan et al., 2012) as well as a pneumococcal
integrative and conjugative element (ICE; Chan et al., 2014;
Iannelli et al., 2014) warrants further investigations. Another
interesting ζ homolog is found in the genomes of several bacteria.
These ζ homologs are much larger than either ζ or PezT
and are found not associated with a corresponding ε or PezA
antitoxins (Chan et al., 2012). The functionality of these solitary ζ
homologs was enigmatic as overexpression of a homolog from
Acinetobacter baumannii was reportedly non-lethal (Jurenaite
et al., 2013). However, the Meinhart group in a recent report has
elegantly demonstrated that one of these solitary ζ homologs in
E. coli, designated EzeT, consisted of a toxin domain in the C-
terminal and an antitoxin domain in the N-terminal in a single
polypeptide chain (Rocker and Meinhart, 2015a). E. coli cells
that expressed full-length EzeT grew normally with no UNAG-
3P detected. However, in cells that expressed an EzeT variant
EzeT1N83, that had its first 83 amino acid residues from the
N-terminal deleted, a strong reduction in viability was observed
in parallel with increased cell permeabilization and accumulation
of UNAG-3P. Co-expression of the toxin domain (EzeT1N83)
and the N-terminal antitoxin domain [EzeT(1-82)] from separate
expression vectors led to similar growth profiles as for full-
length EzeT, indicative of trans-complementation (Rocker and
Meinhart, 2015a). Intriguingly, it was found that the toxicity of
EzeT1N83 was only evident at low temperatures (below 30◦C)
and at 37◦C, EzeT was non-functional (Rocker and Meinhart,
2015a) similar to what was reported for the GraTA system of
the soil bacterium Pseudomonas putida (Tamman et al., 2014).
Whether EzeT is autoregulated like other type II TA systems
is still unknown and transcription is likely initiated from a
weak promoter with a conventional −10 hexamer but without
a −35 element (Rocker and Meinhart, 2015a). Nevertheless,
a closer examination of solitary or orphan toxin homologs is
clearly needed as EzeT has been demonstrated to be likely a new
type of TA system in which a cis-acting antitoxin is tethered
to the toxin within a single polypeptide. Besides that, large,
possibly multi-domain ζ-toxin homologs linked to phosphatase
or peptidoglycan-binding domains have been detected along
with other toxin families such as ParE, Fic/Doc, and PemK as
parts of multi-domain proteins (Rocker and Meinhart, 2015b).
Their characterization and biological functions await further
investigations.
The VapBC TA system is by far the most numerous among
TA families with many bacterial genomes containing multiple
vapBC loci (Pandey and Gerdes, 2005; Leplae et al., 2011; Shao
et al., 2011). The VapC toxins are characterized by a PIN
(PilT N-terminus) domain and display similarities to several
nuclease domains. VapC from enterobacteria are tRNAses that
inhibit global translation by site-specific cleavage of tRNAfMet
between the anticodon stem and loop (Winther and Gerdes,
2011) whereas the VapC toxins from other bacterial species have
different RNA target specificities (Ahidjo et al., 2011; McKenzie
et al., 2012). As with other type II TAs, the VapBC complexes
bind to operators in the promoter regions to autoregulate
transcription (Robson et al., 2009; Winther and Gerdes, 2012).
However, the vapBC-1 locus of nontypeable Haemophilus
influenzae showed notable differences as in stark contrast to
other VapBC homologs and type II TA systems that have been
described, the VapC-1 toxin possesses DNA binding activity
whereas the VapB-1 antitoxin does not interact directly with
DNA (Cline et al., 2012). However, VapB-1 increases the affinity
of VapC-1 for DNA and confers specificity for the operator site
for the VapBC complex. The vapBC-1 locus is also regulated by
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the FIS which is responsible for activation of vapBC-1 during
nutrient upshifts (Cline et al., 2012). During nutrient starvation
conditions, VapB-1 would be degraded by endogenous proteases,
releasing active VapC-1 toxins, and facilitating entry of H.
influenzae cells into the persister state. When conditions favor
cellular growth, FIS activates vapBC-1 transcription and displaces
any bound VapC-1 on the operator site (which is unstable in
the absence of VapB-1). Levels of FIS decreases during early
exponential growth, and this allows the VapBC-1 complex to bind
and restore transcriptional equilibrium (Cline et al., 2012).
CONCLUSIONS AND PERSPECTIVES
Our knowledge on toxin-antitoxin systems has indeed come a
long way since they were coined as “addiction” modules that
function to ensure the stable maintenance of plasmids in the
absence of selection pressure by killing off any plasmid-free
daughter cells that developed following cell division. The near
ubiquity of these systems in prokaryotic genomes and their
wide variety reflect their myriad functions in the prokaryotic
lifestyle. The antitoxins are central to the proper functioning
of these TA systems and in this review, we delved in detail
on how these antitoxins usually play dual roles in regulating
the expression of the TA operon as well as neutralizing the
lethal action of the toxins during normal cellular growth, i.e.,
keeping the proverbial wolves at bay. In most cases, cellular
survival hinges on maintaining the balance between the amounts
of toxin and its cognate antitoxin. Hence we have seen how
some TA systems have evolved beyond the basic autoregulatory
circuit to incorporate additional regulatory elements. Such
further complexities to the regulation of TA expression are
speculated to provide additional possibilities to fine-tune and
optimize the production of toxin and antitoxin under diverse
environmental conditions enabling the cells to better adapt
to rapid fluctuations. Such rapid fluctuations may be extreme
in soil-inhabiting bacteria and related environmental niches
whereas bacteria that lead a relatively “comfortable” life in a host
such as pneumococci in biofilms in the human nasopharynx may
have to more frequently confront changes in the host immune
system. As the ectopic expression of some of the bacterial TA
toxin genes leads to severe growth defects and cell death, there
has been increasing interest in TAs as potential targets for
novel antimicrobial agents. Several strategies have been proposed
and developed to enable toxin activation in pathogenic bacteria
such as interfering with the TA complex formation or the
transcription of the operon itself through ligands that block
the interaction of the antitoxin with the operator site. These
and the potential for exploiting TAs as antimicrobial agents
have been recently reviewed (Alonso et al., 2007; Mutschler and
Meinhart, 2011; Williams and Hergenrother, 2012; Tanouchi
et al., 2013; Hayes and Kêdzierska, 2014; Chan et al., 2015).
TAs have also been harnessed as tools for biotechnology and
molecular biology such as in the development of positive
selection plasmid vectors (Stieber et al., 2008; Unterholzner et al.,
2013). The discovery of their functionality in eukaryotic cells have
opened up interesting avenues for research and development
including as anticancer and antiviral gene therapies, and as a
containment system for genetically modified organisms (de la
Cueva-Méndez et al., 2003; Chono et al., 2011; de la Cueva-
Méndez and Pimentel, 2013; Shimazu et al., 2014; Wieteska
et al., 2014; Chan et al., 2015; Preston et al., 2015; Yeo et al.,
2016). With more TAs being discovered and characterized in
the coming months and years ahead, our understanding of
their variety and complexity, particularly in the regulatory
circuits of these small genetic loci, will be greatly enhanced.
Additional knowledge on these systems would enable novel and
improved strategies for harnessing TAs for various biomedical
and biotechnological applications. These serve to underline the
importance and essentiality of TA systems in modulating the
prokaryotic lifestyle.
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